India to United States: Topotecan Export Trade Route
India has recorded 8 verified shipments of Topotecan exported to United States, representing a combined trade value of $216.3K USD. This corridor is served by 1 active Indian exporters, with an average shipment value of $27.0K USD. The leading Indian exporter is INTAS PHARMACEUTICALS LIMITED, which accounts for 100% of total export value with 8 shipments worth $216.3K USD. On the buying side, EVERSANA LIFE SCIENCES SERVICES,LLC is the largest importer in United States with $121.8K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Topotecan corridor is one of India's established pharmaceutical export routes, with 8 shipments documented worth a combined $216.3K USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's topotecan manufacturing sector.
Across 1 active suppliers, the average shipment value stands at $27.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 26.4%, placing it at rank #11 among India's top topotecan export destinations globally.
On the import side, key buyers of Indian topotecan in United States include EVERSANA LIFE SCIENCES SERVICES,LLC, EVERSANA LIFE SCIENCES SERVICES LLC, EVERSANA LIFE SCIENCES SERVICESLLC. EVERSANA LIFE SCIENCES SERVICES,LLC is the single largest importer with 4 shipments valued at $121.8K USD.
Route Characteristics
- Average transit20 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portSAHAR AIR
Market Position
- Global rank#11
- Annual growth+26.4%
- Demand growth+22.2%
- Regulatory ease67/100
Top 10 Indian Topotecan Exporters to United States
Showing top 10 of 1 Indian suppliers exporting Topotecan to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED Avg $27.0K per shipment | 8 | $216.3K | 100.0% |
This table shows the top 10 of 1 Indian companies exporting topotecan to United States, ranked by total trade value. The listed exporters are: INTAS PHARMACEUTICALS LIMITED. INTAS PHARMACEUTICALS LIMITED is the dominant supplier with 8 shipments worth $216.3K USD, giving it a 100% market share.
Top 10 Topotecan Importers in United States
Showing top 10 of 3 known buyers in United States receiving Topotecan shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian topotecan in United States include EVERSANA LIFE SCIENCES SERVICES,LLC, EVERSANA LIFE SCIENCES SERVICES LLC, EVERSANA LIFE SCIENCES SERVICESLLC. The largest importer is EVERSANA LIFE SCIENCES SERVICES,LLC, accounting for $121.8K USD across 4 shipments — representing 56% of all topotecan imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCES SERVICES,LLC | 4 | $121.8K | 56.3% |
| 2 | EVERSANA LIFE SCIENCES SERVICES LLC | 3 | $70.2K | 32.5% |
| 3 | EVERSANA LIFE SCIENCES SERVICESLLC | 1 | $24.3K | 11.2% |
Top 10 Topotecan Formulations Imported by United States
Showing top 10 of 7 product formulations shipped on the India to United States Topotecan route, ranked by trade value
United States imports a wide range of topotecan formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHA.DRU & MEDI, TOPOTECAN FOR INJ 4 MG/VIAL (LYO) EACH VIAL CONTAINSTOPOTECAN HYDROCHLORIDE EQUIVALENT TOTOP — accounts for $78.6K USD across 1 shipments. A total of 7 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHA.DRU & MEDI, TOPOTECAN FOR INJ 4 MG/VIAL (LYO) EACH VIAL CONTAINSTOPOTECAN HYDROCHLORIDE EQUIVALENT TOTOP | 1 | $78.6K | 36.4% |
| 2 | PHARMA DRUGS MEDI TOPOTECAN RTU 1MG ML 4ML 1V ACC US AS PER INVOICE | 2 | $42.9K | 19.8% |
| 3 | PHARMA DRUG MED TOPOTECAN RTU 1MG ML 4ML 1V ACC US Each mL cont Topot Hydroc eq to Topotecan 1 0mg War for Inj ASPERIN | 1 | $27.3K | 12.6% |
| 4 | PHA.DRU & MEDI TOPOTECAN RTU 1MG/ML 4ML 1V(ACC-US) Each mL contains: Topotecan Hydrochloride eq to Topotec | 1 | $24.3K | 11.2% |
| 5 | PHA.DRU & MEDI, TOPOTECAN RTU 1MG/ML, 4ML 1V(ACC-US) EACH ML CONTAINS: TOPOTECAN HYDROCHLORIDE EQ TO TOPOTECA | 1 | $24.2K | 11.2% |
| 6 | PHA.DRU & MEDI, TOPOTECAN RTU 1MG/ML, 4ML 1V(ACC-US) Each mL contains: Topotecan Hydrochloride eq to Topoteca | 1 | $9.8K | 4.5% |
| 7 | PHA.DRU & MEDI, TOPOTECAN RTU 1MG/ML, 4ML 1V(ACC-US) Each mL contains: Topotecan Hydrochloride eq to Topotec | 1 | $9.2K | 4.2% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 67% sea for bulk, 16% air for urgent orders.
Top Ports of Origin
SAHAR AIR handles the highest volume with 5 shipments. Transit time averages 20 days by sea.
Market Dynamics
India's topotecan exports to United States are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 8 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $27.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as pharma drugs medi topotecan rtu 1mg ml 4ml 1v acc us as per invoice and pharma drug med topotecan rtu 1mg ml 4ml 1v acc us each ml cont topot hydroc eq to topotecan 1 0mg war for inj asperin, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, EVERSANA LIFE SCIENCES SERVICES,LLC is the largest importer with 4 shipments worth $121.8K USD — representing 56% of all topotecan imports from India on this route.
Route Statistics
- Trade Volume
- $216.3K
- Avg. Shipment
- $27.0K
- Suppliers
- 1
- Buyers
- 3
- Transit (Sea)
- ~20 days
- Annual Growth
- +26.4%
Other Topotecan Routes
Unlock the Full India to United States Topotecan Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 8 shipments on this route.
Frequently Asked Questions — India to United States Topotecan Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Topotecan to United States?
The leading Indian exporters of Topotecan to United States are INTAS PHARMACEUTICALS LIMITED. INTAS PHARMACEUTICALS LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Topotecan exports from India to United States?
India exports Topotecan to United States worth approximately $216.3K USD across 8 recorded shipments. The average value per shipment is $27.0K USD.
Q Which ports does India use to ship Topotecan to United States?
The most active port of origin is SAHAR AIR with 5 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 67% of shipments going by sea and 16% by air.
Q How long does shipping take from India to United States for Topotecan?
The average transit time for Topotecan shipments from India to United States is approximately 20 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to United States Topotecan trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 26.4% with demand growth tracking at 22.2%. The route is ranked #11 among India's top Topotecan export destinations globally.
Q How many suppliers are active on the India to United States Topotecan route?
There are currently 1 active Indian suppliers exporting Topotecan to United States. The market is moderately concentrated with INTAS PHARMACEUTICALS LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Topotecan from India in United States?
The leading importers of Indian Topotecan in United States include EVERSANA LIFE SCIENCES SERVICES,LLC, EVERSANA LIFE SCIENCES SERVICES LLC, EVERSANA LIFE SCIENCES SERVICESLLC. EVERSANA LIFE SCIENCES SERVICES,LLC is the largest buyer with 4 shipments worth $121.8K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Topotecan.
- 2.Supplier/Buyer Matching: 1 Indian exporters and 3 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 8 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
8 Verified Shipments
1 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists